Aescap Genetics Newsletter Q2 2022

Strong clinical study data delivered across the portfolio. Genetics technologies are increasingly being used in the development of innovative medicines. While in the beginning R&D in genetics companies was focused on (inborn) genetic diseases using cell, gene or RNA therapy, these technologies are now exploited in a much broader manner.

Aescap Genetics Newsletter Q2 2022